UGenome
  • Home
    • 1-minute UGenome overview
  • About
    • UGenome in the News
    • About
    • Contact
    • Team
    • Advisors
    • Partners & Collaborators
    • UGenome’s Mission, Vision, Values
    • UGenome Policies October 2025
    • Investors
  • Genomic Software
  • Bioinformatics
    • Bioinformatics Services
    • Bioinformatics Case Studies
  • Medication Response Solutions
    • UGenome’s PGx Case Studies
    • Emerging Trends
    • Rare Disease & Women’s Health Resources
    • Dictionary
Select Page

Pharmacogenomics: Rethinking Mental Health

by Brooks | Jul 6, 2025 | Emerging Trends, Mental Health and Psychiatry, Pharmacogenomics

Jennifer Tovar, PharmD & Hanna M. Schultze, MD, DE, EMBA Pharmacogenomics: Rethinking Mental Health. How might pharmacogenomics (PGx) reshape the treatment paradigm for mental health disorders? Mental health PGx is a rapidly evolving field at the intersection of...

Mental Health in Pregnancy: Advancing Care Through Pharmacogenomics

by Brooks | May 22, 2025 | Emerging Trends, Mental Health and Psychiatry, Women's Health

Miley Nguyen, PharmD & Husna Rahim, PharmD Mental Health in Pregnancy: Advancing Care Through Pharmacogenomics. How can pharmacogenomics (PGx) enhance mental health treatment during pregnancy? Hormonal fluctuations during pregnancy significantly increase the risk...

Have YOU EVER WONDERED…how genetics shapes antidepressant response in women?

by Brooks | May 22, 2025 | Mental Health and Psychiatry, Pharmacogenomics, Women's Health, Wondered?

Navya Brinda & Jennifer Tovar, PharmD Have YOU EVER WONDERED…how genetics shapes antidepressant response in women? Women face a higher risk of depression due to hormonal fluctuations and genetic polymorphisms in serotonin-related pathways (Radosavljevic et...

How Pharmacogenomics Reshapes Mental Health

by Brooks | Jan 18, 2025 | Emerging Trends, Mental Health and Psychiatry

Ezra Smith, PhD & Zachary Brooks, PhD How Pharmacogenomics Reshapes Mental Health. How does the study of genes affect our understanding of medications? By analyzing genes, scientists and clinicians alike more precisely understand drug interactions with the body....

Pharmacogenomics: Effective and reliable Clinical Trials for Depression

by Brooks | Dec 30, 2024 | Emerging Trends, Mental Health and Psychiatry

Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD Pharmacogenomics: Effective and reliable Clinical Trials for Depression. With mental health taking center stage post-COVID-19 pandemic, what are some new ways to improve the treatment of depression? One...

Pharmacogenomics in Mental Health: A Look at Schizophrenia

by Brooks | Dec 29, 2024 | Emerging Trends, Mental Health and Psychiatry

Husna Rahim, PharmD & Kate Choy-Kay Lee Pharmacogenomics in Mental Health: A Look at Schizophrenia. How can pharmacogenomics (PGx) be leveraged to optimize treatments for patients suffering from mental illness? In contrast to diseases of physical manifestation,...

Recent Posts

  • Could Genetic Biomarkers Transform Kidney Disease Treatment?  
  • How Do National Genome Projects Advance the Power of Pharmacogenomics? 
  • How can Pharmacogenomics Protect Older Adults from the Risks of Polypharmacy?
  • Can Genetic Insights Refine Arrhythmia Treatment?
  • Pharmacogenomics, Nutrigenomics, and Longevity

Recent Comments

No comments to show.

UGenome Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Sign up for UGenome's Newsletter on LinkedIn!

 

Click Here
Website built by The Free Website Guys 🚀
  • Follow
  • Follow